United States Interventional Neurology Market Outlook to 2023

  • ID: 4296596
  • Report
  • Region: United States
  • 79 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • DePuy Synthes Inc
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corp
  • MORE
United States Interventional Neurology Market Outlook to 2023

Summary

The author’s new report, "United States Interventional Neurology Market Outlook to 2023", provides key market data on the United States Interventional Neurology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Aneurysm Clips, Embolization and Coiling Devices, Navigational System and Neurovascular Stents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Interventional Neurology market segments - Aneurysm Clips, Embolization and Coiling Devices, Navigational System and Neurovascular Stents.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Interventional Neurology market.
- Key players covered include Stryker Corporation, Medtronic plc, DePuy Synthes Inc and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • DePuy Synthes Inc
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corp
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Interventional Neurology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Interventional Neurology Market, United States
3.1 Interventional Neurology Market, United States, Revenue ($m), 2009-2016
3.2 Interventional Neurology Market, United States, Revenue ($m), 2016-2023
3.2.1 Embolization and Coiling Devices Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.2 Navigational System Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.3 Embolization and Coiling Devices Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.4 Navigational System Market, United States, Revenue ($m), by Segment, 2016-2023
3.3 Interventional Neurology Market, United States, Volume (Units), 2009-2016
3.4 Interventional Neurology Market, United States, Volume (Units), 2016-2023
3.4.1 Embolization and Coiling Devices Market, United States, Volume (Units), by Segment, 2009-2016
3.4.2 Navigational System Market, United States, Volume (Units), by Segment, 2009-2016
3.4.3 Embolization and Coiling Devices Market, United States, Volume (Units), by Segment, 2016-2023
3.4.4 Navigational System Market, United States, Volume (Units), by Segment, 2016-2023
3.5 Interventional Neurology Market, United States, Average Price ($), 2009-2023
3.6 Interventional Neurology Market, United States, Distribution Share by Revenue ($m), 2015-2016
3.7 Interventional Neurology Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Interventional Neurology Market
4.1 DePuy Synthes Inc
4.1.1 Company Overview
4.2 Stryker Corporation
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
4.4 Terumo Corp
4.4.1 Company Overview
5 Interventional Neurology Market Pipeline Products
6 Financial Deals Landscape
6.1 Asset Transactions
6.1.1 Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion
6.2 Equity Offerings
6.2.1 AxoGen Raises USD20 Million in Public Offering of Shares
6.3 Venture Financing
6.3.1 NeuroVasc Technologies Raises USD1 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors
7.1.2 Jan 05, 2017: AxoGen Appoints Ivica Ducic Medical Director
7.1.3 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors
7.1.4 Nov 15, 2016: Penumbra Announces Resignation of Board Member
7.1.5 Sep 19, 2016: AxoGen Appoints Amy Wendell to Board of Directors
7.1.6 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations
7.2 Financial Announcements
7.2.1 May 08, 2017: Collaboration Helps Broaden Access To Pfizer's Contraceptive, Sayana Press (Medroxyprogesterone Acetate), For Women In Some Of The World's Poorest Countries
7.2.2 May 04, 2017: Uni-Bio Science Launches Best-in-Class Oral Anti-Diabetic Drug Mitiglinide Branded (Bokangtai)
7.2.3 May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results
7.2.4 Apr 25, 2017: Stryker reports first quarter 2017 results
7.2.5 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results
7.2.6 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results
7.2.7 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results
7.2.8 Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results
7.2.9 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
7.2.10 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results
7.2.11 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
7.2.12 Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue
7.2.13 Nov 10, 2016: Symic Bioand Nordic Bioscience Complete Enrollment of Modify-OA Trial of SB-061 for the Treatment of Osteoarthritis
7.2.14 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results
7.2.15 Nov 02, 2016: AxoGen Reports Financial Results for Third Quarter 2016
7.2.16 Oct 27, 2016: Stryker reports third quarter 2016 results
7.2.17 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
7.2.18 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results
7.2.19 Aug 03, 2016: AxoGen Reports Financial Results for Second Quarter 2016
7.2.20 Jul 21, 2016: Stryker reports second quarter 2016 results
7.2.21 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results
7.2.22 May 09, 2016: Osprey Medical Presents AVERT Trial Results at SCAI Annual Meeting
7.2.23 May 09, 2016: Penumbra Reports First Quarter 2016 Financial Results
7.3 Legal And Regulatory
7.3.1 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
7.4 Other Significant Developments
7.4.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
7.4.2 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care
7.4.3 Sep 15, 2016: Silk Road Medical Announces New Medicare Coverage Option for TransCarotid Artery Revascularization Procedures
7.5 Product News
7.5.1 Sep 12, 2016: AxoGen to Participate at the American Association of Oral and Maxillofacial Surgeons 98th Annual Meeting
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking

List of Tables
Table 1: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 4: Navigational System Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Navigational System Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 7: Interventional Neurology Market, United States, Volume (Units), Historic, 2009-2016
Table 8: Interventional Neurology Market, United States, Volume (Units), Forecast, 2016-2023
Table 9: Embolization and Coiling Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 10: Navigational System Market, United States, Volume (Units), Historic, 2009-2016
Table 11: Embolization and Coiling Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 12: Navigational System Market, United States, Volume (Units), Forecast, 2016-2023
Table 13: Interventional Neurology Market, United States, Average Price ($), Historic, 2009-2016
Table 14: Interventional Neurology Market, United States, Average Price ($), Forecast, 2016-2023
Table 15: Interventional Neurology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Interventional Neurology Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Interventional Neurology Market Pipeline Products
Table 18: Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion
Table 19: AxoGen Raises USD20 Million in Public Offering of Shares
Table 20: NeuroVasc Technologies Raises USD1 Million in Venture Financing

List of Figures
Figure 1: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 4: Navigational System Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 5: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 6: Navigational System Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Interventional Neurology Market, United States, Volume (Units), Historic, 2009-2016
Figure 8: Interventional Neurology Market, United States, Volume (Units), Forecast, 2016-2023
Figure 9: Embolization and Coiling Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 10: Navigational System Market, United States, Volume (Units), Historic, 2009-2016
Figure 11: Embolization and Coiling Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 12: Navigational System Market, United States, Volume (Units), Forecast, 2016-2023
Figure 13: Interventional Neurology Market, United States, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • DePuy Synthes Inc
  • Stryker Corporation
  • Medtronic Plc
  • Terumo Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll